Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5068569
Reference Type
Journal Article
Title
Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets
Author(s)
Mendes, CP; Postal, BG; Oliveira, GTC; Castro, AJG; Frederico, MJS; Moraes, ALL; Neuenfeldt, PD; Nunes, RJ; Menegaz, D; Silva, FRMB
Year
2018
Is Peer Reviewed?
Yes
Journal
Journal of Cellular Physiology
ISSN:
0021-9541
EISSN:
1097-4652
Volume
234
Issue
1
Page Numbers
509-520
Language
English
PMID
29968920
DOI
10.1002/jcp.26746
Web of Science Id
WOS:000451533300041
URL
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050503998&doi=10.1002%2fjcp.26746&partnerID=40&md5=bd0656647671b021da73856de6809bd2
Exit
Abstract
New compounds with promising antidiabetic activity were synthesized. For the first time, a portion of the glibenclamide molecule was bound to a part of the core structure of thiazolidinedione to evaluate insulin secretagogue activity. Following studies in our laboratory, 4-{2-[2-(3,4-dichlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]ethyl}benzene-1-sulfonamide (DTEBS) was selected to evaluate glycemia using the glucose tolerance test and insulin secretagogue activity by E.L.I.S.A. The mechanism of action of this compound was studied by 45 Ca2+ influx and whole-cell patch-clamp in rat pancreatic isolated islets. Furthermore, AGE formation in vitro was investigated. We herein show that this novel hybrid compound (DTEBS) exhibits an insulinogenic index and a profile of serum insulin secretion able to maintain glucose homeostasis. Its mechanism of action is mediated by ATP-sensitive potassium channels (KATP) and L-type voltage-dependent calcium channels (VDCC) and by activating protein kinase C and A (PKC and PKA). In addition, the stimulatory action of the compound on calcium influx and insulin secretion indicates that the potentiation of voltage-sensitive K+ currents (Kv) is due to the repolarization phase of the action potential after secretagogue excitation-secretion in pancreatic islets. Furthermore, under these experimental conditions, the compound did not induce toxicity and the in vitro late response of the compound to protein glycation reinforces its use to prevent complications of diabetes. DTEBS exerts an insulin secretagogue effect by triggering KATP, VDCC, and Kv ionic currents, possibly via PKC and PKA pathway signal transduction, in beta-cells. Furthermore, DTEBS may hold potential for delaying the late complications of diabetes.
Tags
•
Ethylbenzene
LitSearch Update 2019
PubMed
WOS
New Litsearch 4/2019
PubMed
Toxline
WOS
Litsearch Update April 2020
WOS
Litsearch Update April 2023
SCOPUS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity